摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-1-amino-3-(4-(3-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-5-yl)-2-ethyl-6-methylphenoxy)propan-2-ol | 1062671-14-0

中文名称
——
中文别名
——
英文名称
(S)-1-amino-3-(4-(3-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-5-yl)-2-ethyl-6-methylphenoxy)propan-2-ol
英文别名
——
(S)-1-amino-3-(4-(3-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-5-yl)-2-ethyl-6-methylphenoxy)propan-2-ol 化学式
CAS
1062671-14-0
化学式
C24H33N5O3
mdl
——
分子量
439.558
InChiKey
MFUDARFOPMVNMZ-FQEVSTJZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.52
  • 重原子数:
    32.0
  • 可旋转键数:
    10.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    110.53
  • 氢给体数:
    2.0
  • 氢受体数:
    8.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    羟基乙酸(S)-1-amino-3-(4-(3-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-5-yl)-2-ethyl-6-methylphenoxy)propan-2-ol 1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.17h, 以85 mg的产率得到(S)-N-(3-(4-(3-(2-(diethylamino)-6-methylpyridin-4-yl)-[1,2,4]oxadiazol-5-yl)-2-ethyl-6-methylphenoxy)-2-hydroxypropyl)-2-hydroxyacetamide
    参考文献:
    名称:
    Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines
    摘要:
    In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P(1) agonists such as the thiophene derivative 1. As a continuation of these efforts, we replaced the thiophene in 1 by a 2-, 3-, or 4-pyridine and obtained less lipophilic, potent, and selective S1P(1) agonists (e.g., 2) efficiently reducing blood lymphocyte count in the rat. Structural features influencing the compounds' receptor affinity profile and pharmacokinetics are discussed. In addition, the ability to penetrate brain tissue has been studied for several compounds. As a typical example for these pyridine based S1P(1) agonists, compound 53 showed EC50 values of 0.6 and 352 nM for the S1P(1), and S1P(3) receptor, respectively, displayed favorable PK properties, and penetrated well into brain tissue. In the rat, compound 53 maximally reduced the blood lymphocyte count for at least 24 h after oral dosing of 3 mg/kg.
    DOI:
    10.1021/jm4014696
  • 作为产物:
    描述:
    2-甲基-6-乙基苯胺sodium chloritesodium dihydrogenphosphate dihydrate乌洛托品硫酸 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 N,N-二异丙基乙胺 、 sodium hydroxide 、 sodium nitrite 作用下, 以 甲醇二氯甲烷二甲基亚砜异丙醇 为溶剂, 反应 44.0h, 生成 (S)-1-amino-3-(4-(3-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-5-yl)-2-ethyl-6-methylphenoxy)propan-2-ol
    参考文献:
    名称:
    Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines
    摘要:
    In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P(1) agonists such as the thiophene derivative 1. As a continuation of these efforts, we replaced the thiophene in 1 by a 2-, 3-, or 4-pyridine and obtained less lipophilic, potent, and selective S1P(1) agonists (e.g., 2) efficiently reducing blood lymphocyte count in the rat. Structural features influencing the compounds' receptor affinity profile and pharmacokinetics are discussed. In addition, the ability to penetrate brain tissue has been studied for several compounds. As a typical example for these pyridine based S1P(1) agonists, compound 53 showed EC50 values of 0.6 and 352 nM for the S1P(1), and S1P(3) receptor, respectively, displayed favorable PK properties, and penetrated well into brain tissue. In the rat, compound 53 maximally reduced the blood lymphocyte count for at least 24 h after oral dosing of 3 mg/kg.
    DOI:
    10.1021/jm4014696
点击查看最新优质反应信息